• Commitments for A$8.0 million capital raise through secured convertible notes
• Tranche 1 of A$2.6 million to be issued immediately, Tranche 2 of A$5.4 million subject to shareholder approval
• Convertible notes have 14% interest rate until maturity, 18% after maturity

Enlitic, Inc. (ASX: ENL) ('Enlitic' or the 'Company') has secured commitments for a capital raise of A$8.0 million through the issue of secured convertible notes to a group of sophisticated investors (the 'Convertible Notes'). Approximately A$2.6 million will be received in an initial tranche, with the balance of A$5.4 million subject to shareholder approval. The Convertible Notes will have a maturity date of 30 September 2026 and will be secured by a first priority security interest over the Company's assets. The Convertible Notes will be convertible into CHESS Depositary Interests over shares of common stock in the capital of the Company (CDIs) at an initial conversion price of A$0.025 per Convertible Note, with the conversion price after the maturity date representing a 25% discount to the 10-day VWAP of CDIs. The Company can redeem the Convertible Notes at any time, and the Noteholder can redeem the Convertible Notes after the maturity date. The Company intends to use the proceeds to support the continued commercialisation and scaling of its AI-enabled healthcare solutions and to provide working capital. While the Company continues to see positive progress, the timing of achieving cash flow breakeven is now expected to extend beyond the current period.

The Company now expects the timing of achieving cash flow breakeven to extend beyond the current period, reflecting the cadence of customer implementation, contract ramp-up and scaling activities, rather than any change in underlying market demand or strategic focus.